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Abstract
Background: Prostaglandin E2 (PGE2), an arachidonic acid metabolite converted by cyclooxygenase-2 (COX-2),
plays important roles in the regulation of endothelial functions in response to bacterial infection. The enzymatic
activity of COX-2 can be down-regulated by heme oxygenase-1 (HO-1) induction. However, the mechanisms
underlying HO-1 modulating COX-2 protein expression are not known.
Objective: The aim of the present study was to investigate whether the up-regulation of HO-1 regulates COX-2
expression induced by lipopolysaccharide (LPS), an endotoxin produced by Gram negative bacteria, in mouse brain
endothelial cells (bEnd.3)
Methods: Cultured bEnd.3 cells were used to investigate LPS-induced COX-2 expression and PGE2 production.
Cobalt protoporphyrin IX (CoPP, an HO-1 inducer), infection with a recombinant adenovirus carried with HO-1
gene (Adv-HO-1), or zinc protoporphyrin (ZnPP, an HO-1 inhibitor) was used to stimulate HO-1 induction or inhibit
HO-1 activity. The expressions of COX-2 and HO-1 were evaluated by western blotting. PGE2 levels were detected
by an enzyme-linked immunoassay. Hemoglobin (a chelator of carbon monoxide, CO, one of metabolites of HO-1)
and CO-RM2 (a CO releasing molecule) were used to investigate the mechanisms of HO-1 regulating COX-2
expression.
Results: We found that LPS-induced COX-2 expression and PGE2 production were mediated through NF-B (p65)
via activation of Toll-like receptor 4 (TLR4). LPS-induced COX-2 expression was inhibited by HO-1 induction by
pretreatment with CoPP or infection with Adv-HO-1. This inhibitory effect of HO-1 was reversed by pretreatment
with either ZnPP or hemoglobin. Pretreatment with CO-RM2 also inhibited TLR4/MyD88 complex formation, NF-B
(p65) activation, COX-2 expression, and PGE2 production induced by LPS.
Conclusions: We show here a novel inhibition of HO-1 on LPS-induced COX-2/PGE2 production in bEnd.3. Our
results reinforce the emerging role of cerebral endothelium-derived HO-1 as a protector against cerebral vascular
inflammation triggered by bacterial infection.
Background
Sepsis is a life-threatening clinical syndrome which is
correlated with a mortality of 30% [1]. During Gram
negative sepsis, lipopolysaccharide (LPS), an endotoxin
produced by Gram negative bacteria, stimulates various
pro-inflammatory cytokines and mediators releasing
[2]. For example, prostaglandin E2 (PGE2), an arachi-
donic acid metabolite synthesized by cyclooxygenase-2
(COX-2) which is a key enzyme involved in the
LPS-induced inflammatory process [3], is a potent pro-
inflammatory mediator and plays important physiologi-
cal/pathological roles in the regulation of vascular
endothelial function [4,5].
LPS may reach the brain tissue via blood stream and
induce neuronal injury during bacterial infection [6].
LPS-induced brain inflammation was closely associated
with increased oxidative stress [7,8]. Therefore, LPS has
been extensively used to study the possible linkage
between inflammation and brain injury [9]. In the brain,
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stress have been reported to be diminished by heme
oxygenase-1 (HO-1) [10-12], an inducible form of HO
which is an enzyme catalyzing the degradation of heme
into carbon monoxide (CO), biliverdin, and free iron.
HO-1 is one of the major acute-phase proteins up-
regulated upon exposure to oxidative stresses [13-15].
Moreover, increasing evidence indicates that CO, a by-
product of HO-1, may protect against LPS-induced
endothelial injury, suggesting that the production of CO
by HO-1 exerts protective effects against LPS-induced
endothelial injury [16].
COX-2 is an enzymatic heme protein [17]. HO-1 con-
trols the availability of heme for synthesis of enzymatic
heme proteins (e.g. COX-2), and generates CO, which
binds the heme moiety of heme protein thus affecting
their enzymatic activity [18]. In consequence, the effect
of HO-1 on COX-2 protein in vascular endothelial cells
is one of significant physiological/pathological modula-
tion. However, there are few studies investigating
whether the up-regulation of COX-2 protein can be
modulated by HO-1. The effect of HO-1 on LPS-
induced COX-2 expression in cerebral endothelial cells
has not yet been elucidated.
Thus, experiments were performed using a mouse
brain endothelial cell line (bEnd.3) to investigate
whether HO-1 regulates LPS-induced COX-2 expression
in these cells. Our results demonstrate that LPS-induced
COX-2 expression and PGE2 production is inhibited by
induction of HO-1. This inhibitory effect of HO-1 is
mediated through an HO-1 byproduct, CO, which
attenuates TLR4/MyD88 complex formation and NF-B
activation induced by LPS. These results suggest that
cerebrovascular endothelium-derived HO-1 may prevent
vascular inflammation which is triggered by bacterial
infection in the brain.
Methods
Materials
Dulbecco’s modified Eagle’s medium (DMEM) and fetal
bovine serum (FBS) were purchased from Invitrogen
(Carlsbad, CA, USA). Polyclonal antibodies HO-1,
TLR4, and MyD88 were purchased from Santa Cruz
(Santa Cruz, CA, USA). Anti-COX-2 antibody was pur-
chased from BD Transduction Laboratories (San Diego,
CA, USA). Anti-GAPDH antibody was purchased from
Biogenesis (Boumemouth, UK). Anti-phospho-NF-B
p65 antibody was purchased from Cell Signaling
(Danver, MA, USA). Bay117082 was purchased from
Biomol (Plymouth Meeting, PA, USA). Bicinchoninic
acid (BCA) protein assay reagent was purchased from
Pierce (Rockford, IL, USA). Hemoglobin, biliverdin
reductase, enzymes, and other chemicals were purchased
from Sigma (St. Louis, MO, USA).
Cell cultures
Mouse brain endothelial cells (bEnd.3, ATCC CRL-
2299) were grown in DMEM/F-12 containing 10% FBS
and antibiotics (100 U/ml penicillin G, 100 μg/ml strep-
tomycin, and 250 ng/ml fungizone) at 37°C in a humidi-
fied 5% CO2 atmosphere. When the cultures grew to
confluence (about 4 days), cells were detached with
0.05% (w/v) trypsin/0.53 mM EDTA for 5 min at 37°C.
The cell suspension was diluted with DMEM/F-12 con-
taining 10% FBS to a concentration of 2 × 10
5 cells/ml.
The cell suspension was plated onto 12-well culture
plates (1 ml/well) for the measurement of protein
expression and enzymatic assays. Culture medium was
changed after 24 h and every 3 days. Experiments were
performed with cells from passages 5 to 13.
Preparation of recombinant adenovirus infection
A recombinant adenovirus containing HO-1 (Adv-HO-1)
was kindly provided by Dr. L.Y. Chau (Institute of Biome-
dical Sciences, Academia Sinica, Taipei, Taiwan). Recom-
binant adenovirus was generated by homologous
recombination and amplified in 293 cells. Large scales of
viral vectors were purified by CsCl ultracentrifugation
a n ds t o r e di n1 0m MT r i s - H C l( p H7 . 4 ) ,1m MM g C l 2,
a n d1 0 %( v / v )g l y c e r o la t- 8 0 ° Cu n t i lu s e df o re x p e r i -
ments. Virus titers were determined by a plaque assay on
a 293 cell monolayer. The recombinant adenovirus was
diluted with DMEM/F12 medium and added directly to
the cells (MOI = 10). After 24 h of infection, the cells
were incubated with LPS for another 24 h. Cell lysates
were analyzed by western blotting.
ll extract preparation and western blot
Western blot analysis was performed as previously
described [19]. bEnd.3 cells were lysed with a sample
buffer (125 mM Tris-BASE, 5% Glycerol, 3% b-mer-
captoethanol, 1.25% SDS and 0.0005% Bromophenol
blue). Cell lysates were denatured, subjected to SDS-
PAGE using a 12% running gel and transferred onto a
nitrocellulose membrane. Membranes were incubated
with a mouse anti-COX-2 antibody (1:1000 dilution)
or a goat anti-HO-1 antibody (1:1000 dilution) at 4°C
for 24 h, and then incubated with an anti-mouse or
anti-goat horseradish peroxidase antibody (1:2000 dilu-
tion, at room temperature for 1 h), respectively. The
gel bands were detected by ECL reagents and were
quantified by a densitometry.
Immunoprecipitation assay
The bEnd.3 cells were grown to confluence and starved
for 24 h in serum-free DMEM/F-12 medium. Cells were
pretreated with CO-RM2 (CO releasing molecule, 50
μM) for 2 h prior to the application of LPS. The cells
were washed, scraped, and centrifuged to prepare
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described [20]. Membrane fractions containing 1 mg of
protein were incubated with 2 μg of anti-TLR4 antibody
at 4°C for 24 h, and then 10 μl of 50% protein A-agarose
beads was added and mixed at 4°C for another 24 h.
The immunoprecipitates were collected and subjected to
electrophoresis on 12% SDS-PAGE, transferred to nitro-
cellulose membrane, and then blotted using an anti-
MyD88 or anti-TLR4 antibody. The gel bands were
detected by ECL reagents and were quantified by a
densitometry.
Enzymatic assay for HO-1 activity
HO activity was measured as the level of bilirubin for-
mation using the microsomal fraction of cells [21].
Briefly, bEnd.3 cells were washed twice with PBS, gently
scraped off the dish, and centrifuged (1000 ×g, 10 min,
4°C). The cell pellet was suspended in MgCl2 (2 mM)
and phosphate (100 mM) buffer (pH 7.4), frozen at
-70°C, thawed thrice, and finally sonicated on ice before
centrifugation at 18,000 ×g for 10 min at 4°C. The
supernatant (400 μl) was added to a reaction mixture
(200 μl final volume, pH 7.4) containing NADPH
(0.8 mM), glucose-6-phosphate (2 mM), glucose-6-
phosphate-1-dehydrogenase (0.2 U), and 2 mg of rat
liver cytosol as a source of biliverdin reductase, PBS
(100 mM), and the substrate hemin (10 μM). The reac-
tion was conducted for 1 h at 37°C in the dark and ter-
minated by addition of 1 ml chloroform. The reaction
without the NADH served as a control. The extracted
bilirubin was measured by the difference in absorption
between 464 and 530 nm (extinction coefficient = 40
mM
-1·cm
-1) with a spectrophotometer. HO activity was
expressed as picomoles of bilirubin per milligram of
protein per hour.
Measurement of PGE2 generation
bEnd.3 cells were cultured in 12-well culture plates.
After reaching confluence, cells were pretreated with
CoPP, ZnPP, or CO-RM2 for the indicated time inter-
vals, and then incubated with LPS (100 μg / m l )a t3 7 ° C
for 24 h. The levels of PGE2 released into the culture
medium were collected and stored at -80°C until being
assayed by using a commercially available PGE2
enzyme immunoassay kit (Cayman Chemicals, Ann
Arbor, MI). Both the samples and standards were
assayed in parallel.
Statistical analysis of data
Data were analyzed using a GraphPad Prism Program
(GraphPad, San Diego, CA, USA). Quantitative data
were analyzed using one-way analysis of variance
(ANOVA) followed by Tukey’s honestly significant
difference tests between individual groups. Data were
expressed as mean ± SEM. A value of P < 0.05 was con-
sidered significant.
Results
LPS induces COX-2 expression and PGE2 synthesis in
bEnd.3 cells
To determine the effect of LPS on COX-2 expression,
bEnd.3 cells were incubated with various concentrations
of LPS for the indicated time intervals. As shown in Fig-
ure 1A and 1B, LPS induced COX-2 expression in a
time- and concentration-dependent manner. LPS (100
μg/ml)-induced COX-2 protein expression was signifi-
cantly increased within 6 h and sustained over 24 h. To
further determine if LPS-induced COX-2 expression
required ongoing transcription or translation, cells were
pretreated with either a transcriptional level inhibitor
[actinomycin D (Act.D)] or a translational level inhibitor
[cycloheximide (CHI)] for 1 h and then incubated with
LPS (100 μg / m l )f o r2 4h .A ss h o w ni nF i g u r e1 Ca n d
1D, LPS-mediated induction of COX-2 expression was
abolished by pretreatment with either Act.D or CHI in a
concentration-dependent manner. Pretreatment with
these two inhibitors alone had no effect on COX-2
expression. In addition, we found that LPS (100 μg/ml)
markedly increased COX-2 enzyme activity, revealed as
PGE2 production (Figure 1E). Taken together, these
findings demonstrated that the induction of COX-2 by
LPS depends on de novo protein synthesis.
LPS-induced COX-2 expression is mediated through NF-
B activation
To investigate the role of NF-B in LPS-mediated
COX-2 expression, cells were pretreated with an inhibi-
tor of NF-B, Bay117082 for 1 h, and then incubated
with LPS for 24 h. As shown in Figure 2A, Bay117082
markedly inhibited LPS-induced COX-2 expression, sug-
gesting that NF-B may play an important role in LPS-
induced COX-2 expression. Next, we investigated
whether the involvement of NF-Bi nL P S - m e d i a t e d
responses was mediated through activation of NF-B
(p65). As shown in Figure 2B, LPS stimulated phos-
phorylation of NF-B (p65) in a time-dependent man-
ner, which was inhibited by pretreatment with
Bay117082. To further investigate whether activation of
NF-B was mediated through TLR4 receptors, cells
were pretreated with a TLR4 antibody (5 mg/ml) for 1
h, and then incubated with LPS for the indicated time
intervals. As shown in Figure 2C, pretreatment with
TLR4 antibody also inhibited LPS-stimulated phosphor-
ylation of NF-B (p65). These data indicated that LPS-
induced COX-2 expression was mediated through a
TLR4/NF-B cascade in bEnd.3 cells.
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expression and NF-B (p65) phosphorylation
HO-1 has been shown to exert cytoprotective and anti-
inflammatory effects in stress conditions. Therefore, we
investigated whether induction of HO-1 attenuated
LPS-mediated responses in bEnd.3 cells. As shown in
Figure 3A, pretreatment with CoPP (an HO-1 inducer)
induced HO-1 protein expression in a concentration-
dependent manner in bEnd.3 cells. Pretreatment with
CoPP (0.3 μM) for 24 h markedly increased HO-1
Figure 1 LPS induces COX-2 protein expression and activity. A,
B: bEnd.3 cells were incubated with various concentrations of LPS
for the indicated time intervals. The expression of COX-2 was
determined by western blot.*P < 0.05;
#P < 0.01, as compared with
the cells exposed to the vehicle. C, D: Cells were pretreated with
either actinomycin D (Act.D) or cycloheximide (CHI) for 1 h, and
then incubated with LPS for 24 h. The expression of COX-2 was
determined by western blot. *P < 0.05;
#P < 0.01, as compared with
the cells incubated with LPS alone. E: Cells were incubated with 100
μg/ml LPS for 24 h. PGE2 production was determined as the activity
of COX-2. Data are summarized and expressed as mean ± SEM of
four individual experiments. *P < 0.05, as compared with the cells
exposed to the vehicle.
Figure 2 LPS-induced COX-2 expression via NF-B activation.
A: Cells were pretreated with an inhibitor of NF-B, Bay117082, for
1 h and then incubated with LPS (100 mg/ml) for 24 h. The
expression of COX-2 was determined by western blot. *P < 0.05;
#P < 0.01, as compared with the cells incubated with LPS alone. B,
C: Cells were pretreated with either Bay117082 or TLR 4 antibody
for 1 h and then stimulated with LPS (100 mg/ml) for the indicated
time intervals. Phosphorylation of NF-B p65 was determined by
western blot. Data are summarized and expressed as mean ± SEM
of four individual experiments. *P < 0.05;
#P < 0.01 as compared
within groups. NS: not significant.
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activity inhibitor) (Figure 3B). Interestingly, pretreatment
with CoPP resulted in a significant attenuation of LPS-
induced COX-2 protein expression (Figure 3C). NF-Bi s
a crucial transcription factor for COX-2 expression, we
determined the effect of HO-1 on LPS-stimulated NF-B
activation by measuring NF-B (p65) phopshorylation.
As shown in Figure 3D, LPS-stimulated NF-B (p65)
phosphorylation was also inhibited by pretreatment with
CoPP (0.3 μM, 24 h), during the period of observation.
These data indicated that LPS-induced COX-2 expres-
sion and NF-B (p65) phosphorylation was attenuated by
up-regulation of HO-1 in bEnd.3 cells.
HO-1 over-expression attenuates LPS-induced COX-2
expression and PGE2 synthesis
To ensure that HO-1 induction decreased LPS-induced
COX-2 expression, bEnd.3 cells were pretreated with an
HO-1 inducer (CoPP) or an HO-1 functional inhibitor
(ZnPP). As shown in Figure 4A, pretreatment with
CoPP attenuated LPS-induced COX-2 protein expres-
sion and PGE2 synthesis. These inhibitory effects of
CoPP were reversed by ZnPP. To further confirm the
effect of HO-1 overexpression induced by CoPP on
LPS-mediated responses, bEnd.3 cells were transfected
with either adenovirus or recombinant adenovirus carry-
ing the human HO-1 (Adv-HO-1). As shown in Figure
4 B ,t r a n s f e c t i o nw i t ha d v - H O - 1( A d v ,M O I=1 0 ,4 8h )
enhanced HO-1 expression and attenuated LPS-induced
COX-2 expression. In contrast, transfection with adeno-
virus alone had no effect on HO-1 and COX-2 expers-
sion. This inhibitory effect was reversed by a chelator of
carbon monoxide, hemoglobin (Hb, 200 mg/ml). These
results suggested that overexpression of HO-1 by pre-
treatment with CoPP or transfection with adv-HO-1
attenuated LPS-induced COX-2 expression, at least in
part, mediated through an HO-1 byproduct, CO.
CO inhibits LPS-induced COX-2 expression and PGE2
synthesis in bEnd.3 cells
To further determine whether CO attenuated LPS-
induced COX-2 expression, bEnd.3 cells were pretreated
with a CO releasing molecule (CO-RM2). As shown in
Figure 5A, LPS-induced COX-2 protein expression was
inhibited by pretreatment with CO-RM2 in a concentra-
tion manner. Pretreatment with CO-RM2 also attenu-
ated LPS-induced PGE2 synthesis (Figure 5B). We
further determined whether the inhibitory effect of CO
on LPS-induced responses was due to the attenuation
of NF-B activation. As shown in Figure 5C, LPS-
stimulated NF-B (p65) phosphorylation was also inhib-
ited by pretreatment with CO-RM2.
LPS has been shown to activate NF-Bm e d i a t e d
through TLR4 leading to the expression of COX-2 [22].
Figure 3 LPS-induced COX-2 expression is attenuated by
pretreatment with CoPP in bEnd.3 cells. A: Cells were incubated
with various concentrations of CoPP for 24 h. Expression of HO-1
was determined by western blot. *P < 0.05;
#P < 0.01 as compared
the cells incubated with vehicle alone. B: Cells were pretreated with
vehicle or ZnPP (0.1 μM) for 1 h and then incubated with CoPP
(0.3 μM) for 24 h. HO-1 enzyme activity was determined.
#P < 0.01
as compared within groups. C: Cells were pretreated with various
concentrations of CoPP for 24 h and then incubated with LPS
(100 mg/ml) for 24 h. The expression of COX-2 was determined by
western blot. *P < 0.05;
#P < 0.01, as compared with the cells
incubated with LPS alone. D: Cells were pretreated with CoPP
(0.3 μM) for 24 h and then stimulated with LPS (100 mg/ml) for the
indicated time intervals. The phosphorylation of NF-B p65 was
determined by western blot. Data are summarized and expressed as
mean ± SEM of four individual experiments. *P < 0.05;
#P < 0.01, as
compared within groups. NS: not significant.
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COX-2 expression and PGE2 synthesis in bEnd.3 cells. A: Cells
were pretreated with or without ZnPP for 1 h, incubated with CoPP
for 24 h, and then incubated with LPS (100 mg/ml) for another 24
h. The media were used to determine the levels of PGE2. The
expression of COX-2 and HO-1 were determined by western blot.
B: Cells were pretreated with or without hemoglobin (Hb) for 1 h,
infected with adenovirus (MOI = 10) or recombinant adenovirus
carrying the human HO-1 gene treatment (Adv-HO-1, MOI = 10) for
48 h, and then incubated with LPS (100 mg/ml) for another 24 h.
The levels of COX-2 and HO-1 expression were determined by
western blot. Data are summarized and expressed as mean ± SEM
for four individual experiments. *P < 0.05;
#P < 0.01 as compared
within groups.
Figure 5 CO inhibits LPS-induced COX-2 protein expression
and PGE2 synthesis in bEnd.3 cells. A: Cells were pretreated with
CO-RM2 (CO releasing molecule) for 2 h and then incubated with
LPS (100 mg/ml) for 24 h. The expression of COX-2 was determined
by western blot. *P < 0.05;
#P < 0.01, as compared with the cells
incubated with LPS alone. B: Cells were pretreated with CO-RM2 (50
mM, 2 h) and then incubated with LPS (100 mg/ml) for 24 h. The
media were used to determine the levels of PGE2.* P < 0.05;
#P <
0.01, as compared within groups. C: Cells were pretreated with CO-
RM2 (CO releasing molecule) for 2 h and then incubated with LPS
(100 mg/ml) for the indicated time intervals. Phosphorylation of NF-
B p65 was determined by western blot. *P < 0.05;
#P < 0.01, as
compared within groups. NS: not significant. D: Cells were treated
with or without CO-RM2 (50 μM, 2 h) followed by LPS treatment
(100 mg/ml) for the indicated time intervals. Cell lysates were
immunoprecipitated with an anti-TLR4 antibody. The
immunoprecipiates were analyzed by western blot using anti-
MyD88 or anti-TLR4 (input) antibody. Data are summarized and
expressed as mean ± SEM for four individual experiments. *P < 0.05
as compared within groups.
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induced COX-2 expression through interruption of
either NF-B or TLR4 in these cells. We tested the
effect of CO-RM2 on LPS-induced protein-protein
interaction between TLR4 and its adaptor protein mye-
loid differentiation factor (MyD88) which was shown to
initiate an early activation of NF-B in endothelial cells
[23]. As shown in Figure 5D, pretreatment with CO-
RM2 inhibited LPS-induced TLR4/MyD88 complex for-
mation in bEnd.3 cells, indicating that CO attenuated
the protein-protein interaction between TLR4 and
MyD88 and thus retardation of COX-2 expression
induced by LPS. These data suggested that LPS-stimu-
lated TLR4/MyD88/NF-B activation and COX-2
expression was blocked by CO in bEnd.3 cells.
Discussion
PGs secreted by inflammatory cells are important in
early initiation of inflammatory responses. PGE2 is
thought to be a mediator of inflammation and pain
[4,5]. COX-2, a key enzyme catalyzing the rate-limiting
step in the inducible production of PGs, has been sug-
gested to contribute to cellular damage. Therefore,
COX-2 inhibition is suggested to be beneficial for cellu-
lar survive. In the present study, LPS-induced COX-2
expression and PGE2 synthesis was inhibited by HO-1
induction by pretreatment with either CoPP or Adv-
HO-1 in murine bEnd.3 cells. Some studies also demon-
strated an inhibitory effect of HO-1 on PGs production.
Up-regulation of the HO-1 gene or pretreatment with
an HO-1 inducer, SnCl2, attenuated angiotensin II-
induced COX-2 and PG synthesis in endothelial cells
[24]. Pretreatment with CoPP decreased PGE2 produc-
tion by inhibiting microsomal prostaglandin E synthase-
1 expression in primary cultured chondrocytes [25].
These data suggest that overexpression of HO-1 exerts
an inhibitory effect on COX-2 expression and PGs pro-
duction in different cell types. In contrast, an HO-1
inducer, CKD712, showed a weak inhibitory effect on
COX-2 and PGE2 induced by LPS in RAW264.7 cells
[26]. Therefore, the effect of HO-1 on expression of
inflammatory proteins and mediators may be controver-
sial. In the present study, our results are the first report
to show that induction of HO-1 attenuates LPS-induced
COX-2 expression and PGE2 synthesis in endothelial
cells. Cerebral vascular endothelium-derived HO-1 may
contribute to the prevention of vascular inflammation
triggered by bacterial infection in mouse brain. LPS has
b e e ns h o w nt oi n d u c et i s s u ei n j u r yb yd a m a g i n g
the nutritive microcirculation and by stimulating the
release of cytokines [27]. HO-1 may protect against
LPS-mediated injury by attenuating the expression
of inflammatory mediators and improving microva-
scular perfusion. In the present study, we found that
pre-induction of HO-1 attenuate LPS-induced expres-
sion of COX-2 protein and therefore decreased PGE2
accumulation. The role of HO-1 over-expression in
COX-2 induction as well as PGE2 synthesis induced by
various stimuli remains to be investigated.
Bernardini et al. [16] have shown that levels of HO-1,
Hsp70, and Egr-1 proteins are increased within 4-15 h
after LPS (10 μg/ml) administration in porcine aortic
endothelial cells (pAEC). LPS (10 μg/ml, 15 h) also
increases apoptosis rates about 4-7 folds in pAEC. Because
HO-1 plays a protecting role in stress conditions, it is rea-
sonable that 10 μg/ml of LPS damaged the pAEC and also
induced HO-1 protein expression to defend against the
injury insults. In our study, there was no COX-2 protein
expression induced by LPS at 25 μg/ml for 24 h.
The required concentration of LPS to induce significant
COX-2 protein expression in bEnd.3 cells was a concen-
tration of 100 μg/ml for 24 h. At this concentration,
neither was cell damage observed nor HO-1 expression
increased in bEnd.3 cells. This discrepancy may be due to
different experimental conditions or to cell specificity.
Carbon monoxide (CO) is one of the main metabo-
lites of heme degradation by HO-1 [28,29]. Its anti-
inflammatory, anti-apoptotic and cytoprotective
properties are well documented in different experimen-
tal models [15]. There is growing evidence to demon-
strate the role of CO as anti-inflammatory and
cytoprotective functions of HO-1 in various cell types
[30-32]. The HO/CO signaling pathway plays an
important role in host defense mechanisms, including
inhibition of TLR4 signaling stimulated by LPS
[33-35]. In the present study, LPS-induced COX-2
expression and PGE2 production was inhibited by pre-
t r e a t m e n tw i t he i t h e rC o P Po rC O - R M 2 .T h i si n h i b i -
tory effect was reversed by pretreatment with ZnPP, an
HO-1 activity inhibitor, and hemoglobin, a chelator of
CO, suggesting that the inhibitory effect of HO-1 on
COX-2 expression was partially mediated through CO.
Consistent with our report, CO has been shown to
down-regulate LPS-induced COX-2 expression and
PGE2 secretion by inhibiting CCAAT/enhancer-binding
protein (C/EBP) in LPS-treated RAW 264.7 cells [36].
In addition to CO, biliverdin and bilirubin have been
reported to protect cells from the insult of oxidative
stress in HO-1 siRNA-transfected HT22 cells [37]. The
roles of biliverdin and bilirubin on LPS-induced COX-
2 expression needs further investigating.
The transcription factor NF-B is a major mediator of
LPS signaling [38]. LPS-activated NF-B is an important
transcription factor for expression of inflammatory pro-
teins. NF-B is a downstream component of tyrosine
phosphorylation. LPS has been shown to activate NF-B
through TLR4 leading to the expression of COX-2 [22].
It has also been reported that the attenuation of NF-B
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HO-1 in various cell types [26]. Interestingly, CO has
been reported to modulate several transcription factors,
including NF-B [30,31]. In the blood/vascular system,
pretreatment of human umbilical vein endothelial cells
(HUVEC) with CO-RM2 attenuates the LPS-induced
activation of NF-B [32]. Recently, CO has also been
shown to block LPS-induced initial inflammatory
response through inhibition of NF-Bi nh u m a nm o n o -
cytes [35]. In the present study, we found that LPS-
induced COX-2 expression and p65 activation was
inhibited by pretreatment with CoPP and CO-RM2,
suggesting that induction of HO-1/CO inhibits LPS-
induced COX-2 by inhibition of NF-B in murine cele-
bral endothelium.
In addition to NF-B inhibition by HO-1/CO, other
transcription factors, such as CCAAT/enhancer-binding
protein (C/EBP) expression are decreased by HO-1/CO
in LPS-treated RAW 264.7 cells [36] and activating pro-
tein (AP)-1 is also suppressed by hemin, an HO-1 indu-
cer, in soleus muscles of Sprague-Dawley rats [39]. It is
interesting that early growth response-1 (Egr-1) protein,
which is a key transcription factor in regulating the
inducible expression of microsomal PGE synthase 1
(mPGES-1) and therefore promotes PGE2 release [40], is
also significantly reduced by an HO-1 inducer, CoPP, in
IL-1b-treated chondrocytes [41]. All of NF-B, C/EBP,
AP-1, and Egr-1 transcription factors are involved in
PGE2 synthesis catalyzed by induction of either COX-2
or mPGES-1. The activation of these transcription fac-
tors is suppressed by induction of HO-1 which exerts
anti-oxidative and anti-inflammatory effects in several
cell types [42], including endothelial cells [43]. We
therefore hypothesized that there is a common mechan-
ism in attenuation of these inflammation-related tran-
scription factors by induction of HO-1/CO in these
cells.
TLRs function as primary sensors of pathogens, which
activate signaling pathways leading to the expression of
cytokines [44]. It has been demonstrated that the signaling
pathways are initiated by LPS binding to the TLR4 in
endothelial cells [23]. Inflammatory signaling initiates when
LPS binds to LPS-binding protein, which presents LPS to
CD14. Binding of LPS to CD14 activates TLR4. Activation
of TLR4 triggers the recruitment of myeloid differentiation
factor (MyD88) and initiates NF-B signaling pathway,
leading to expression of inflammatory target proteins. In
the present study, pretreatment with CO-RM2 attenuated
the association between TLR4 and MyD88 (Figure 5D).
CO-RM2 inhibited LPS-induced activation of NF-B,
which may be due to attenuation of TLR4/MyD88 signal-
ing, consistent with results indicating that CO suppresses
TLR4/MyD88 signaling in murine macrophages [45].
COX-2 has been suggested to contribute to LPS-induced
cellular damage [3]. It has been reported that pretreatment
with a selective COX-2 inhibitor protects neuronal cul-
tures from LPS-induced cytotoxicity through attenuation
of COX-2 expression and PGs synthesis [46]. Interestingly,
COX-2-selective inhibitors have been reported to induce
HO-1 expression in various cell types [47,48]. These
reports suggest that the protective effects of COX-2 inhibi-
tors may be due to HO-1 induction [49]. Furthermore, it
has been also reported that the COX-2 metabolite, PGE2,
induces HO-1 through PKA and PI3K signaling pathways
via EP2 receptors in C6 cells [50]. Induction of HO-1 may
be a defensive response initiated by PGE2 and serve a criti-
cal role for a cytoprotective mechanism during oxidative
stress. There seems to be an interesting interactive
relationship between COX-2 and HO-1, that is, over-
expression of COX-2 associated with PGE2 release induces
HO-1 expression which in turn inhibits COX-2 expression
Figure 6 Down-regulation of LPS-induced COX-2 expression
and PGE2 production by HO-1/CO in bEnd.3 cells. LPS-induced
COX-2 expression and PGE2 production were mediated by a TLR4/
MyD88/NF-B pathway. Induction of HO-1 by pretreatment with
CoPP or infection with Adv-HO-1 attenuated LPS-induced COX-2
expression and PGE2 production in bEnd.3 cells. A HO-1 by-product,
CO, at least in part, attenuated LPS-induced COX-2 expression
through interruption of TLR4/MyD88/NF-B pathway in bEnd.3 cells.
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ship between HO-1 and COX-2 is an interesting issue and
needs detailed investigation.
As depicted in Figure 6, this study demonstrated that
up-regulation of HO-1 inhibits LPS-mediated COX-2
expression and PGE2 synthesis in murine brain endothe-
lial cells (bEnd.3). Treatment of bEnd.3 cells with LPS
induces COX-2 protein and PGE2 via Toll-like receptor
4-mediated activation of NF-B. However, pharmacolo-
gic induction or gene transfer of HO-1 blocks LPS-
mediated COX-2 expression and activity. This inhibitory
effect of HO-1 on COX-2 expression was mediated
through retardation of NF-B and could be reversed by
an HO inhibitor, ZnPP, or a CO-scavenger, hemoglobin.
Moreover, the exogenous administration of the CO
releasing molecule, CO-RM2, mimics the effect of HO-1.
Conclusions
Our results show strong evidence that overexpression of
HO-1/CO exerts an inhibitory effect on LPS-induced
COX-2/PGE2 synthesis in cerebrovascular endothelial
cells. Our results reinforce the emerging role of cerebro-
vascular endothelium-derived HO-1 as a protector for
preventing cerebral vascular inflammation triggered by
bacterial infection.
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